Atlas Trials

A Clinical Trial to Evaluate the Efficacy and Safety of LANLUMA V to Improve Jawline Contour Deficit

Clinical trial NCT06391580 · UNKNOWN

Trial details

NCT number
NCT06391580
Sponsor
Sinclair Pharmaceuticals Limited
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Jawline Contour Deficit
Start date
2024-04-30
Primary completion
2024-04-30
Enrollment
192

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.